Cosmos Health Inc (COSM) is not a strong buy for a beginner investor with a long-term strategy at this time. While the company has shown revenue growth and improving gross margins, the persistent net losses, declining EPS, and overbought technical indicators suggest caution. Additionally, there are no strong trading signals or significant positive catalysts to justify immediate investment.
The MACD is positive and expanding, indicating bullish momentum. However, the RSI is at 86.542, signaling the stock is overbought. Moving averages are converging, suggesting indecision. Key resistance levels are at 0.417 and 0.457, while support levels are at 0.288 and 0.248.

Revenue increased by 83% YoY in FY 2025, with gross margins expected to reach 75% from U.S. operations. The company also reported a significant improvement in gross margin YoY in Q4 2025.
The RSI indicates the stock is overbought, and there are no significant insider or hedge fund trading trends. Additionally, no recent congress trading data or influential figure activity is available.
In Q4 2025, revenue increased by 38.52% YoY to $19.7 million, and gross margin improved by 83.95% YoY to 8.94%. However, net income remained negative at -$10.15 million, and EPS dropped by 31.71% YoY to -0.28.
No recent analyst ratings or price target changes are available for this stock.
